The Gut Microbiome Is Associated with Clinical Response to Anti-PD-1/PD-L1 Immunotherapy in Gastrointestinal Cancer/Experiment 3/Signature 1
From BugSigDB
Reviewed Marked as Reviewed by Folakunmi on 2024-4-9
Source: Fig. 3C, Supp. Table S8
Description: Differential abundance between responders and non-responders to Anti–PD-1/PD-L1 Immunotherapy in esophageal carcinoma cancer patients
Abundance in Group 1: increased abundance in Responders (esophageal carcinoma)
Revision editor(s): Scholastica